Natrium Sulfuricum 6x

Anhydrous Sodium Sulfate

Seroyal Usa
Human Otc Drug
NDC 62106-1060

Natrium Sulfuricum 6x also known as Anhydrous Sodium Sulfate is a human otc drug labeled by 'Seroyal Usa'. National Drug Code (NDC) number for Natrium Sulfuricum 6x is 62106-1060. This drug is available in dosage form of Tablet. The names of the active, medicinal ingredients in Natrium Sulfuricum 6x drug includes Sodium Sulfate - 6 [hp_X]/1 . The currest status of Natrium Sulfuricum 6x drug is Active.

Drug Information:

Drug NDC:	62106-1060
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Natrium Sulfuricum 6x
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Anhydrous Sodium Sulfate
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Seroyal Usa
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Tablet
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	SODIUM SULFATE - 6 [hp_X]/1
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	SUBLINGUAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	01 May, 2015
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	24 Dec, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	Seroyal USA
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UNII:	91GQH8I5F7 4J9FJ0HL51 0YPR65R21J
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
62106-1060-2	1 BOTTLE, GLASS in 1 CARTON (62106-1060-2) / 100 TABLET in 1 BOTTLE, GLASS	01 May, 2015	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Natrium Sulfuricum 6x

Anhydrous Sodium Sulfate

Tablet
Seroyal USA
NDC: 62106-1060

Purpose:

Uses for the temporary relief of symptoms associated with mild indigestion.

Uses for the temporary relief of symptoms associated with occasional anxiety overexertion mental fatigue

Uses for the temporary relief of symptoms associated with fever and minor inflammatory conditions.

Product Elements:

Natrium sulfuricum 6x anhydrous sodium sulfate sodium sulfate sodium sulfate anhydrous lactose monohydrate xylitol croscarmellose sodium magnesium stearate kalium phosphoricum 6x potassium dihydrogen phosphate xylitol magnesium stearate croscarmellose sodium lactose monohydrate potassium phosphate, monobasic phosphate ion ferrum phosphoricum 6x hydrated iron iii phosphate ferrosoferric phosphate ferrosoferric phosphate lactose monohydrate xylitol croscarmellose sodium magnesium stearate

Indications and Usage:

Uses for the temporary relief of symptoms associated with mild indigestion. directions tip bottle slightly allowing for tablets to fall into the cap. use cap to drop tablets into mouth and allow them to dissolve under tongue. adults and adolescents (12 years and older): take 1 to 4 tablets, one to four times daily, or as recommended by your healthcare practitioner. children (under 12 years): take under the direction of your healthcare practitioner.

Indications for the temporary relief of symptoms associated with occasional anxiety overexertion mental fatigue directions tip bottle slightly allowing for tablets to fall into the cap. use cap to drop tablets into mouth and allow them to dissolve under the tongue. adults and adolescents (12 years and older): take 1 to 4 tablets, one to four times daily, or as recommended by your healthcare practitioner. children (under 12 years): take under the direction of your healthcare practitioner.

Uses for the temporary relief of symptoms associated with fever and minor inflammatory conditions. directions tip bottle slightly allowing for tablets to fall into the cap. use cap to drop tablets into mouth and allow them to dissolve under the tongue. adults and children (12 years and older): take 1 to 4 tablets, one to four times daily, or as recommended by your healthcare practitioner. children (under 12 years): take under the direction of your healthcare practitioner.

Warnings:

Warnings do not use if you ever had an allergic reaction to this product or any of its ingredients. stop use and ask a doctor if symptoms persist or worsen. if pregnant or breastfeeding, ask a health professional before use. keep out of reach of children. in case of overdose, get medical help or contact a poison control center right away.

Warnings do not use if you ever had an allergic reaction to this product or any of its ingredients. stop use and ask a doctor if symptoms persist or worsen if you are pregnant or breastfeeding, ask a healthcare practitioner before use. keep out of reach of children. in case of overdose, get medical help or contact a poison control center right away.

Dosage and Administration:

Directions tip bottle slightly allowing for tablets to fall into the cap. use cap to drop tablets into mouth and allow them to dissolve under tongue. adults and adolescents (12 years and older): take 1 to 4 tablets, one to four times daily, or as recommended by your healthcare practitioner. children (under 12 years): take under the direction of your healthcare practitioner.

Directions tip bottle slightly allowing for tablets to fall into the cap. use cap to drop tablets into mouth and allow them to dissolve under the tongue. adults and adolescents (12 years and older): take 1 to 4 tablets, one to four times daily, or as recommended by your healthcare practitioner. children (under 12 years): take under the direction of your healthcare practitioner.

Directions tip bottle slightly allowing for tablets to fall into the cap. use cap to drop tablets into mouth and allow them to dissolve under the tongue. adults and adolescents(12 years and older): take 1 to 4 tablets, one to four times daily, or as recommended by your healthcare practitioner. children (under 12 years): take under the direction of your healthcare practitioner.

Overdosage:

In case of overdose, get medical help or contact a poison control center right away.

Package Label Principal Display Panel:

Ndc 62106-1060-2 unda tissue salt natrium sulfuricum 6x homeopathic remedy schuessler salt for the temporary relief of symptoms associated with mild indigestion. 100 tablets 62106-1060-2

Ndc 62106-1055-2 unda tissue salt ndc 62106-1055-2 kalium phosphoricum 6x homeopathic remedy schuessler salt for the temporary relief of symptoms associated with occasional anxiety, overexertion and mental fatigue. 100 tablets 62106-1055-2

Ndc 62106-1053-2 unda tissue salt ferrum phosphoricum 6x homeopathic remedy cell salt for the temporary relief of symptoms associated with fever and minor inflammatory conditions. 100 tablets 62106-1053-2

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.